Spots Global Cancer Trial Database for Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
Official Title: A Phase 1 Study of Vinorelbine Liposomes Injection (VLI) for Treatment in Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease
Study ID: NCT00364676
Study Description
Brief Summary: This Phase 1 study will determine the safety, tolerability, and pharmacokinetics of vinorelbine liposomes injection (VLI) in patients with advanced solid tumors, non-Hodgkin's lymphoma, or Hodgkin's disease.
Detailed Description: The objectives of this study are: * To assess the safety and tolerability of treatment with VLI. * To determine the maximum tolerated dose (MTD) of VLI. * To characterize the pharmacokinetic (PK) profile of VLI. * To explore preliminary tumor response of VLI.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer Therapy and Research Center, San Antonio, Texas, United States
South Texas Accelerated Research Therapeutics, San Antonio, Texas, United States
McGill Centre for Translational Research in Cancer-Jewish General Hospital Clinical Research Unit, Montreal, Quebec, Canada
Contact Details
Name: John Sarantopoulos, MD
Affiliation: Cancer Therapy and Research Center, Texas
Role: PRINCIPAL_INVESTIGATOR
Name: Gerald Batist, MD
Affiliation: McGill Centre for Translational Research in Cancer-Jewish General Hospital Clinical Research Unit
Role: PRINCIPAL_INVESTIGATOR
Name: Anthony W. Tolcher, MD
Affiliation: South Texas Accelerated Research Therapeutics
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
